BRWM
ABBV icon

B. Riley Wealth Management’s AbbVie ABBV Stock Holding History

B. Riley Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$12.5K Sell
81,306
-27,512
-25% -$4.2M 0.01% 118
2022
Q1 		$14.3M Sell
108,818
-763
-0.7% -$111K 1.1% 14
2021
Q4 		$12M Buy
109,581
+2,211
+2% +$261K 0.83% 21
2021
Q3 		$9.34M Buy
107,370
+4,576
+4% +$523K 0.72% 26
2021
Q2 		$9.24M Buy
102,794
+20,244
+25% +$2.28M 1.02% 21
2021
Q1 		$8.93M Buy
82,550
+3,629
+5% +$388K 1.04% 26
2020
Q4 		$8.46M Sell
78,921
-6,261
-7% -$602K 1.09% 22
2020
Q3 		$7.46M Buy
85,182
+15,838
+23% +$1.49M 0.88% 28
2020
Q2 		$6.81M Sell
69,344
-3,301
-5% -$291K 0.75% 34
2020
Q1 		$5.54M Buy
72,645
+55,275
+318% +$4.71M 0.58% 45
2019
Q4 		$1.54M Buy
17,370
+6,860
+65% +$570K 0.23% 102
2019
Q3 		$796K Buy
10,510
+1,014
+11% +$69.5K 0.14% 154
2019
Q2 		$690 Sell
9,496
-1,144
-11% -$89.9K 0.11% 172
2019
Q1 		$858K Buy
10,640
+2,163
+26% +$177K 0.15% 151
2018
Q4 		$782K Buy
8,477
+703
+9% +$61.8K 0.16% 137
2018
Q3 		$735K Buy
+7,774
New +$737K 0.18% 115
2016
Q1 		$258K Buy
4,525
+294
+7% +$16.4K 0.39% 90
2015
Q4 		$250K Sell
4,231
-2,002
-32% -$115K 0.32% 113
2015
Q3 		$339K Buy
6,233
+1,512
+32% +$98.4K 0.48% 73
2015
Q2 		$317K Buy
4,721
+771
+20% +$50.3K 0.25% 114
2015
Q1 		$231K Buy
3,950
+11
+0.3% +$665 0.17% 177
2014
Q4 		$257K Sell
3,939
-714
-15% -$45K 0.21% 122
2014
Q3 		$268K Buy
4,653
+7
+0.2% +$389 0.2% 143
2014
Q2 		$262K Sell
4,646
-196
-4% -$10.3K 0.17% 162
2014
Q1 		$249K Buy
+4,842
New +$245K 0.18% 147

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

B. Riley Wealth Management's ABBV Position: Q2 2022 in Review

B. Riley Wealth Management reduced its AbbVie (ABBV) stake by 25% in Q2 2022, selling an estimated $4.2M and leaving 81,306 shares worth $12.5K. The position accounts for 0.01% of the portfolio, ranked #118.

B. Riley Wealth Management first reported a position in ABBV in Q1 2014 and has held it in 25 quarters since. The position peaked at $14.3M in Q1 2022. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • B. Riley Wealth Management held 81,306 shares of AbbVie worth $12.5K as of Q2 2022.
  • B. Riley Wealth Management sold 27,512 AbbVie shares in Q2 2022, an estimated $4.2M.
  • AbbVie made up 0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #118 holding.
  • B. Riley Wealth Management first reported a position in AbbVie in Q1 2014 and has held it in 25 quarters since.
  • B. Riley Wealth Management's AbbVie position peaked at $14.3M in Q1 2022.
  • 3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.